- Dominic Kwesi Quainoo, Nadiya Habib. Mechanisms of gut microbiota dysbiosis and colorectal cancer risk: Analysis and prospective interventions. Asia-Pac J Oncol 2024

- Tymofiy Lutsiv, Hisham Hussan, Henry J. Thompson. Ecosystemic Approach to Understanding Gut Microbiome–Mediated Prevention of Colorectal Cancer. Cancer J 2024;30:329

- Lulu He, Chenyi Zhao, Jingjing Xu, Wenjing Li, Yujie Lu, Yang Gong, Dingyi Gu, Xiaoyan Wang, Feng Guo. A potential novel biomarker: comprehensive analysis of prognostic value and immune implication of CES3 in colonic adenocarcinoma. J Cancer Res Clin Oncol 2023;149:13239

- Linsen Shi, Lihua Jin, Wendong Huang. Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases. Cells 2023;12:1888

- Roghayeh Nouri, Alka Hasani, Kourosh Masnadi Shirazi, Fatemeh Yeganeh Sefiadn, Fariba Naeimi Mazraeh, Simin Sattarpour, Mohammad Ahangarzadeh Rezaee. Colonization of the gut mucosa of colorectal cancer patients by pathogenic mucosa-associated Escherichia coli strains. Diagnostic Microbiology and Infectious Disease 2024;109:116229

- Gissel García Menéndez, Liubov Sichel, Maria del Consuelo López, Yasel Hernández, Ernesto Arteaga, Marisol Rodríguez, Vilma Fleites, Lipsy Teresa Fernández, Raúl De Jesus Cano, Muhammad Shahid Riaz Rajoka. From colon wall to tumor niche: Unraveling the microbiome’s role in colorectal cancer progression. PLoS ONE 2024;19:e0311233

- Paola Bianchimano, Paola Leone, Emma M. Smith, Cristina Gutierrez-Vazquez, Erli Wind-andersen, Gerold Bongers, Sebastian Cristancho, Howard L. Weiner, Jose C. Clemente, Stephanie K. Tankou. Oral vancomycin treatment alters levels of indole derivatives and secondary bile acids modulating the expression of mTOR pathway genes in astrocytes during EAE. Brain, Behavior, and Immunity 2025;125:355

- Hua Guo. Interactions between the tumor microbiota and breast cancer. Front. Cell. Infect. Microbiol. 2025;14

- Naiyu Liu, Shuxi Liu, Xiaoyue Xu, XianXian Nong, Hong Chen. Organoids as an in vitro model to study human tumors and bacteria. Journal of Surgical Oncology 2024;129:1390

- Yuhang Zhou, Wenjie Han, Yun Feng, Yue Wang, Tao Sun, Junnan Xu. Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review). Int J Oncol 2024;65

- 平 盛. Progress in Surgical Treatment of Colorectal Cancer. ACM 2023;13:17887

- Zongjiong Mai. Citraconate promotes the malignant progression of colorectal cancer by inhibiting ferroptosis. Am J Cancer Res 2024;14:2790

- Jianlu Zheng, Wencui Zhang, Yanli Gong, Wenlang Liang, Yongxiang Leng. A novel near-infrared polymethine dye biosensor for rapid and selective detection of lithocholic acid. Biosensors and Bioelectronics 2024;259:116383

- Zhenyu Dong, Ruixian Shi, Pengda Li, Xiaobiao Song, Fan Dong, Jianmin Zhu, Riga Wu, Zhi Liang, Mingyue Du, Jijun Wang, Zhigang Yang. Does postcholecystectomy increase the risk of colorectal cancer?. Front. Microbiol. 2023;14

- Jianing Yu, Lu Li, Xufeng Tao, Yanwei Chen, Deshi Dong. Metabolic interactions of host-gut microbiota: New possibilities for the precise diagnosis and therapeutic discovery of gastrointestinal cancer in the future—A review. Critical Reviews in Oncology/Hematology 2024;203:104480

- Guangquan Zhang, Xiaozhun Huang, Ruixi Li, Shengjie Hong, Xiyan Zheng, Kai Huang, Jicai Wang, Qiang Tao, Xianjie Shi. Molecular and cellular mechanisms of PDAC progression based on RETN-CAP1-mediated macrophage-fibroblast crosstalk: Action of ITGB5 and ITGB1 recombinant proteins. International Journal of Biological Macromolecules 2025;290:139078

- Guoming Chen, Qing Ren, Zilan Zhong, Qianfan Li, Zhiqiang Huang, Cheng Zhang, Hongchao Yuan, Zixin Feng, Bonan Chen, Ning Wang, Yibin Feng. Exploring the gut microbiome’s role in colorectal cancer: diagnostic and prognostic implications. Front. Immunol. 2024;15

- Sabrina Borusak, Karin Denger, Till Dorendorf, Corentin Fournier, Harry Lerner, Olga Mayans, Dieter Spiteller, David Schleheck. Anaerobic Faecalicatena spp. degrade sulfoquinovose via a bifurcated 6-deoxy-6-sulfofructose transketolase/transaldolase pathway to both C2- and C3-sulfonate intermediates. Front. Microbiol. 2024;15

- Robertina Giacconi, Rossella Donghia, Graziana Arborea, Maria Teresa Savino, Mauro Provinciali, Fabrizia Lattanzio, Giusy Rita Caponio, Sergio Coletta, Antonia Bianco, Maria Notarnicola, Caterina Bonfiglio, Giuseppe Passarino, Patrizia D’Aquila, Dina Bellizzi, Pasqua Letizia Pesole. Plasma Bacterial DNA Load as a Potential Biomarker for the Early Detection of Colorectal Cancer: A Case–Control Study. Microorganisms 2023;11:2360

- Jian Guo, Fanqi Meng, Ruixue Hu, Lei Chen, Jiang Chang, Ke Zhao, Honglin Ren, Zengshan Liu, Pan Hu, Guangyi Wang, Jiandong Tai. Inhibition of the NF-κB/HIF-1α signaling pathway in colorectal cancer by tyrosol: a gut microbiota-derived metabolite. J Immunother Cancer 2024;12:e008831

- Marica Colella, Ioannis Alexandros Charitos, Andrea Ballini, Concetta Cafiero, Skender Topi, Raffaele Palmirotta, Luigi Santacroce. Microbiota revolution: How gut microbes regulate our lives. World J Gastroenterol 2023;29:4368

- Zahra Aminzade, Ali Jafari, Aryan Shirani, Hanie Karimi, Mahshad Naserpour, Amirreza Rafiei Javazm, Proushat Shirvani, Dorsa Alijanzadeh, Noosha Samieefar, Nima Rezaei. . 2023.
